Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 328 entries
View as:

S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone

Phase: N/A Priority: Normal
NCT ID: NCT00410813 Org: User:
Start: 03/31/07 End: 01/31/14 Due: 01/31/15

S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers

Phase: N/A Priority: Normal
NCT ID: NCT00996047 Org: User:
Start: 07/31/91 End: 01/31/12 Due: 01/31/13

S1916 Digital Medicine Program for Pain Control in Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT04194528 Org: User:
Start: 01/22/20 End: 09/16/20 Due: 09/16/21

S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00445848 Org: User:
Start: 07/31/07 End: 01/31/14 Due: 01/31/15

SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil

Phase: N/A Priority: Normal
NCT ID: NCT00003254 Org: User:
Start: 04/30/98 End: 10/31/03 Due: 10/31/04

S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00033540 Org: User:
Start: 09/30/03 End: 07/31/11 Due: 07/31/12

S9927 Radiation Therapy After Surgery, Chemotherapy, and/or Hormone Therapy in Stage II Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00005983 Org: User:
Start: 06/30/00 End: 03/31/05 Due: 03/31/06

S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium

Phase: N/A Priority: Normal
NCT ID: NCT00055835 Org: User:
Start: 11/30/02 End: 06/30/06 Due: 06/30/07

Lung-MAP: Rilotumumab and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches

Phase: N/A Priority: Normal
NCT ID: NCT02926638 Org: User:
Start: 06/16/14 End: 10/12/16 Due: 10/12/17

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

Phase: N/A Priority: Normal
NCT ID: NCT06022939 Org: User:
Start: 07/01/24 End: 10/29/30 Due: 10/29/31

S0927:Omega3-Fatty Acid Supp in Treating Muscle&Bone Pain&Stiffness in Pts W/Stg I,II,III Brst Canc Rec'v Hormone Thpy

Phase: N/A Priority: Normal
NCT ID: NCT01385137 Org: User:
Start: 02/29/12 End: 03/31/14 Due: 03/31/15

S8600-S9031-S9333-A, Study of DNA in Samples From Patients With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01434329 Org: User:
Start: 10/31/11 End: 12/31/15 Due: 12/31/16

S1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02164916 Org: User:
Start: 11/30/14 End: 11/19/20 Due: 11/19/21

S9914: Combination Chemotherapy Plus Filgrastim in Untreated Extensive-Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00004137 Org: User:
Start: 10/31/99 End: 11/30/08 Due: 11/30/09

S0000D: Effect of Vitamin E and/or Selenium on Colorectal Polyps in Men Enrolled on SELECT Trial SWOG-S0000

Phase: N/A Priority: Normal
NCT ID: NCT00706121 Org: User:
Start: 06/30/08 End: 01/31/18 Due: 01/31/19

S9313A Protein Expression Analysis of Breast Cancer Tissue Microarrays From Clinical Trial SWOG-9313

Phase: N/A Priority: Normal
NCT ID: NCT00896727 Org: User:
Start: 07/17/06 End: 04/02/09 Due: 04/02/10

S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma

Phase: N/A Priority: Normal
NCT ID: NCT00900263 Org: User:
Start: 06/30/02 End: - Due: -

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

Phase: N/A Priority: Normal
NCT ID: NCT06470243 Org: User:
Start: 11/27/24 End: 04/30/32 Due: 04/30/33

Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)

Phase: N/A Priority: Normal
NCT ID: NCT04871529 Org: User:
Start: 08/10/22 End: 06/26/24 Due: 06/26/25

S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00005832 Org: User:
Start: 06/30/00 End: 10/31/05 Due: 10/31/06

S0022:Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00014196 Org: User:
Start: 03/31/01 End: 03/31/05 Due: 03/31/06

SWOG 8897-A DNA Analysis in Predicting Treatment Outcome in Women With Breast Cancer in SWOG 8897

Phase: N/A Priority: Normal
NCT ID: NCT00896623 Org: User:
Start: 12/31/06 End: 06/30/07 Due: 06/30/08

S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01309672 Org: User:
Start: 08/09/11 End: 04/11/24 Due: 04/11/25

Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00032123 Org: User:
Start: 06/30/02 End: 05/31/06 Due: 05/31/07

S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis

Phase: N/A Priority: Normal
NCT ID: NCT00064337 Org: User:
Start: 01/31/04 End: 11/30/15 Due: 11/30/16